Clincosm LogoSign in Get a demo

ADVANCED HEPATOCELLULAR CARCINOMA (HCC)

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HepaSphere Drug-eluting Bead Transarterial Chemoembolization

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • DEB-TACE plus HAIC or HAIC alone
  • Beijing, Beijing, China
    Beijing Cancer Hospital
May 19, 2023

Advanced Hepatocellular Carcinoma (HCC), Gastric Cancer Metastatic to Liver, Colorectal Cancer Metastatic to Liver Trial in

Recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • +2 more
  • Duarte, California
  • +2 more
Aug 29, 2022

Advanced Hepatocellular Carcinoma (HCC) Trial in China, Singapore (Toripalimab combined with Bevacizumab, Sorafenib)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • Bengbu, Anhui, China
  • +55 more
Jun 22, 2022

Advanced Hepatocellular Carcinoma (HCC) Trial in Hong Kong (MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate)

Terminated
  • Advanced Hepatocellular Carcinoma (HCC)
  • MGD013 monotherapy
  • MGD013 in combination with Brivanib Alaninate
  • Hong Kong, Hong Kong, China
    Prince of Wales Hospital
Jun 8, 2022

ADVANCED HEPATOCELLULAR CARCINOMA (HCC) Trial in Philadelphia (Galunisertib 150mg by mouth twice a day, Stereotactic Body

Completed
  • ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
  • Galunisertib 150mg by mouth twice a day
  • Stereotactic Body Radiotherapy (SBRT)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 10, 2022

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (Toripalimab combined with Bevacizumab)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • Toripalimab combined with Bevacizumab
  • Beijing, China
    Beijing Cancer hospital
Nov 22, 2021

Advanced Hepatocellular Carcinoma (HCC) Trial in Beijing (camrelizumab;Rivoceranib, Rivoceranib, Sorafenib)

Enrolling by invitation
  • Advanced Hepatocellular Carcinoma (HCC)
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 21, 2021

Advanced Hepatocellular Carcinoma (HCC) Trial in China (AK105 Injection, Anlotinib Hydrochloride Capsules, Sorafenib Tosylate

Not yet recruiting
  • Advanced Hepatocellular Carcinoma (HCC)
  • AK105 Injection
  • +2 more
  • Bengbu, Anhui, China
  • +42 more
Apr 13, 2020

Advanced Hepatocellular Carcinoma (HCC) Trial in Taipei (Axitinib, Radiation)

Completed
  • Advanced Hepatocellular Carcinoma (HCC)
  • Taipei, Taiwan
    Shin Kong Wu Ho-Su Memorial Hospital
Sep 19, 2019

Advanced Hepatocellular Carcinoma (HCC) Trial in Worldwide (OSI-906, Placebo)

Terminated
  • Advanced Hepatocellular Carcinoma (HCC)
  • Los Angeles, California
  • +40 more
Aug 31, 2018

Advanced Hepatocellular Carcinoma (HCC) Trial in Dalian (TAE plus P53 gene, TAE)

Unknown status
  • Advanced Hepatocellular Carcinoma (HCC)
  • TAE plus P53 gene
  • TAE
  • Dalian, Liaoning, China
    first affiliated hospital in Dalian University
Jul 23, 2015